Last reviewed · How we verify
NCT05403411
Distance Education for Nursing Students on Critical Thinking
NA trial testing Distance education for nursing students on critical thinking in Critical Thinking in 153 participants. Completed in 8 June 2021.
8 June 2021
Quick facts
| Lead sponsor | Esra Tayaz |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 153 |
| Start date | 9 March 2021 |
| Primary completion | 8 June 2021 |
| Estimated completion | 8 June 2021 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Distance education for nursing students on critical thinking
Conditions studied
- Critical Thinking — all drugs for Critical Thinking →
Sponsor
Esra Tayaz
Who can join
18 and older, any sex, with Critical Thinking. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Critical thinking forms the basis of nursing knowledge. Critical thinking skills constitute a vital part of the nurse's work performance, adaptation, problem solving, awareness of the responsibilities of the profession, and the conceptual understanding of nursing. Due to the increasing number of dependent patients, complex care needs and increasing research in the field of health, intensive care nurses have to think critically in order to learn throughout life, develop professionally, work effectively with teammates, reach care and treatment goals, and contribute to the change of society.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05403411
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05403411 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Esra Tayaz
- Last refreshed: 3 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05403411.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing